Texas A&M Health Sciences Center College of Medicine, Scott & White Clinic, Temple, Texas, USA.
J Neurointerv Surg. 2009 Dec;1(2):168-70. doi: 10.1136/jnis.2009.001867.
The only Food and Drug Administration-approved implant for managing intracranial stenosis is the Wingspan stent. Modification of the standard Wingspan stent delivery procedure has not been previously reported.
Retrospective, single-patient, technical report.
Following uneventful balloon angioplasty, a symptomatic intracranial vertebral artery stenosis was inaccessible to Wingspan stent delivery using standard procedural protocol because of poor proximal guide catheter purchase. After placing a Renegade Hi-Flo microcatheter across the stenosis, the Wingspan stent was transferred to this catheter and advanced to the lesion using a Neuroform stabilizer. Unsheathing of the stent yielded uncomplicated, precise placement of the stent with a good clinical result.
The Wingspan stent transfer technique can be used successfully in the management of intracranial stenotic disease.
唯一经美国食品和药物管理局批准用于治疗颅内狭窄的植入物是 Wingspan 支架。此前尚未报道对标准 Wingspan 支架输送程序进行修改。
回顾性、单患者、技术报告。
在无并发症的球囊血管成形术后，由于近端引导导管的购买不佳，标准手术方案无法将 Wingspan 支架输送到症状性颅内椎动脉狭窄部位。在将 Renegade Hi-Flo 微导管穿过狭窄部位后，将 Wingspan 支架转移到该导管上，并使用 Neuroform 稳定器将其推进病变部位。支架的释放过程顺利，支架位置精确，临床效果良好。
Wingspan 支架输送技术可成功用于治疗颅内狭窄性疾病。
